ERDAFITINIB FOR INTRAVESICAL ADMINISTRATION FOR USE IN THE TREATMENT OF BLADDER CANCER

• Main Authors: GIESING, Dennis, DELAET, Urbain Alfons C, DANIEL, Karen, BEEHARRY, Neil, HEYNS, Philip Erna H, TIAN, Shaozhou Ken, DHONDT, Jens Julien Maurits André, MAMIDI, Srinivas, SMIRNOV, Denis A, PATEL, Jaymala, RAJPUROHIT, Yashoda Rani
• Format: Patent
• Language: English; French
• Published: 22.08.2024
• Subjects: BABY COMFORTERS; CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; DEVICES FOR RECEIVING SPITTLE; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

Provided herein are methods of treatment, erdafitinib for use and use of erdafitinib for the treatment of bladder cancer harboring one or more FGFR alterations comprising locally delivering erdafitinib into the bladder of a patient. L'invention concerne des méthodes de traitement, l'erdafitinib à des fins d'utilisation et l'utilisation d'erdafitinib pour le traitement du cancer de la vessie hébergeant une ou plusieurs altérations du FGFR, comprenant la délivrance locale d'erdafitinib dans la vessie d'un patient.